SIIX Profit Jumps 46% — Margins Say Otherwise

The headline number does all the talking if you let it: SIIX Corporation (TSE: 7613) reported a 45.6% jump in first-half profit to ¥4.6 billion. The stock, which sits around ¥1,580 with a market cap of ¥80.6 billion, is trading at 26 times earnings — a multiple that assumes the turnaround is durable, not temporary. The factor stack tells a different story.

No stock means anything in isolation, so let's break down the four components that actually determine whether this profit surge justifies the multiple: growth, margins, safety, and valuation.

Growth is real but thin. Valuation demands more.

Revenue rose 5.5% year-over-year to ¥150.7 billion in the first half. That's directionally positive for an electronics manufacturing services and components distributor whose business is 65% automotive. But growth of that magnitude, paired with a 26x P/E, only works if the profit jump is structural rather than arithmetic. In our framework, growth alone gets a C+ — adequate direction, insufficient pace to carry a rich multiple.

The forward estimates paint a more optimistic picture. Analysts project 25.3% annual EPS growth, which would support the current valuation if it actually materializes. The revenue side of that same projection — 4.5% per annum — is what keeps the grade from moving higher. You need top-line conviction to sustain 26x earnings.

Margins are the problem. Not a problem in progress — the problem.

Here's the core question the headline skips: was the profit jump driven by the business getting more profitable, or the cost base getting smaller?

The answer is mostly the latter. SIIX cut selling, general, and administrative expenses by ¥19.3 billion year-over-year, driven by workforce reductions. Interest payments fell from ¥1.5 billion to ¥900 million as debt was whittled down. These are real improvements — not accounting tricks. But they're one-time structural changes, not evidence of pricing power or operating leverage.

Operating margin sits at roughly 3.3%. Net margin is about 3.0%, up from 2.6% in the prior year's first quarter. The base was depressed by ¥2.613 billion in special losses from fixed-asset impairment in China and the sale of a Hungary factory, which inflates the year-over-year comparison. Even without those charges, a 3.3% operating margin on ¥150 billion of revenue tells you the business doesn't have pricing control. It's a thin-margin distributor that's gotten better at controlling overhead.

Management's own full-year FY2026 guidance puts operating profit at ¥9.5 billion on ¥300 billion of revenue — a 3.2% operating margin. That's not a margin expansion story. That's a margin maintenance story dressed up in headline earnings growth.

On profitability, SIIX gets a D+. The business is cleaner than it was, but the margins are structurally thin and the guidance confirms they'll stay that way.

Safety is the strongest factor. It's the one doing the heavy lifting.

The equity ratio improved to 52.9%. Long-term borrowings are down ¥6.3 billion, short-term borrowings down ¥2 billion, and bonds were redeemed. Operating cash flow reached ¥26.5 billion last fiscal year. Inventory was compressed by ¥7.6 billion (¥9 billion after foreign-exchange adjustment).

This is the factor stack doing its job: the balance sheet tells a coherent story that the income statement is still catching up to. Safety grade: A-. The restructuring has materially de-risked the company, which is exactly why the stock isn't cheaper despite the weak margins.

Valuation doesn't match the factor mix.

At 26 times earnings with an operating margin management sees staying at 3.2%, SIIX is pricing in durability that the business hasn't earned yet. A typical EMS distributor or component trader commands a multiple closer to 10–15x in a mature market. The premium here is entirely forward-looking — it requires the 25.3% earnings growth to happen, consistently, for the next several years.

The fair-value estimate from a Peter Lynch formula puts the stock at ¥1,422 — about 11% below the current price. That's not a valuation scream, but it's a signal that the multiple has run ahead of the fundamentals.

Valuation grade: C. The balance-sheet cleanup justifies some rerating. It doesn't justify 26x earnings on a 3.2% margin business.

The full-year picture: maintained guidance, not raised.

Management held full-year targets at ¥300 billion in revenue and ¥6 billion in net income despite the strong first-half result. They excluded a Hungarian subsidiary from consolidation and still maintained the outlook, which suggests the second half doesn't have a tailwind built in. The 229.5% projected profit increase for the full year is real — but again, it's anchored to a prior-year base that was crushed by one-time charges.

What would change the grade?

Three things would push SIIX from this cautious reading to a more constructive one:

1. Operating margins expanding above 4% on a run-rate basis — that would signal pricing power or product mix improvement, not just cost cutting.
2. Revenue growth reaccelerating past the 4.5% forecast — the automotive-heavy exposure needs diversification to stick.
3. A clear catalyst in the biopharmaceutical or industrial equipment segments that moves beyond the ¥2.55 billion investment in Continuous Biologics and into revenue.

Until one of those happens, the stock is a balance-sheet recovery story priced like a growth story. That mismatch is the only reason the factor stack reads as cautious.

Bottom line. SIIX isn't a bad company. The restructuring is real, the debt is down, the cash flow is solid, and the balance sheet is materially safer than it was two years ago. But a 46% profit jump on a 3% margin business, trading at 26x earnings, is not the same as a durable turnaround. The factor stack says hold the position and watch whether margins expand or whether the profit growth runs out of runway when the cost-cutting well dries up. The next earnings print on November 6 will tell you which.

Rating: Hold. Watch for operating margin trajectory, not headline earnings.